GALACTIC-HF results

Investigator John Teerlink, MD, FAHA, summarizes the results of GALACTIC-HF, which found that improving cardiac function with omecamtiv mecarbil significantly reduced the risk of a first heart failure event or cardiac death in patients with heart failure with reduced ejection fraction.